Endomines publishes prospectus in connection with Rights Issue

Press release (PDF)
The information in this press release is not intended for distribution, publication or public release, directly or indirectly, in or into, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, Switzerland, the United States or any other jurisdiction where the publication or distribution of this press release may be unlawful. Please see the important notice at the end of this announcement.

Endomines AB, Stock Exchange Release 12 June 2019 at 08:50 CEST

The Board of Directors of Endomines AB (publ) ("Endomines" or the "Company") has prepared a prospectus regarding the rights issue of shares, which today has been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus has also been passported to Finland.

The Rights Issue in brief

The Board of Directors of Endomines AB (publ) ("Endomines" or the "Company") decided May 10, 2019 on a rights issue of approximately MSEK 165 (the "Rights Issue"), and the Annual General Meeting (the "AGM") on June 10, 2019, approved this decision. The proceeds will be used for the scheduled cash payment for the assets bought in Idaho, continued development of Friday, and exploration and start-up of Rescue, Unity and Kimberly, continued exploration along the Karelian Gold Line and strengthen the Company's financial position.

Summary of the Rights Issue

  • The shareholders have preferential rights to subscribe for four (4) new shares for every three (3) existing shares
  • Subscription price in Sweden will be SEK 3.50 per share
  • Subscription price in Finland will be SEK 0.33 per share
  • Rights Issue proceeds will be approx. MSEK 165 before transaction costs, upon full subscription of the Rights Issue
  • Subscription period for the Rights Issue will be June 14 – July 1, 2019
  • The trading period for the subscription rights on Nasdaq Stockholm and Nasdaq Helsinki will be June 14 –25, 2019

Intentions to subscribe from shareholders and other investors
Some of the Company’s existing shareholders have signed undertakings to subscribe for shares in the Rights Issue corresponding to approximately MSEK 16.5, representing 10 percent of the Rights Issue, and certain other shareholders have given a positive indication to subscribe for shares in the Rights Issue corresponding to another approximately MSEK 33, representing 20 percent of the Rights Issue.

For more information regarding the Rights Issue see the prospectus.

Additional information
The Company will distribute an information folder to all shareholders with further instructions for subscription of shares in Sweden (in Swedish) and Finland (in Finnish). The information folder is available in Swedish, Finnish and English on Endomines website: www.endomines.se.

The prospectus, information brochures and subscription forms for subscription of shares in Sweden are available on the Company’s website, www.endomines.com and on Evli’s website, www.evli.com. For subscription of shares in Finland, shareholders or other investors are asked to follow instructions from their bank or other nominee. The printed prospectus will during the subscription period be obtainable, free of charge, from Endomines, phone +46 (0)8 611 66 45, e-mail: info@endomines.com or Evli, phone +46 (0)8 417 80 00, weekdays 9-16. Questions regarding the subscription and payment in both Finland and Sweden are answered by email: operations@evli.com). Questions regarding the subscription and payment in Sweden are answered by the issuing agent Evli, phone +46 (0)8 4 147 80 00. Questions regarding the subscription and payment in Finland are answered by Evli, phone: +358 9 4766 9646, weekdays 9-16.

For further information, please contact:
Marcus Ahlström, Interim CEO, +358 50 544 68 14, marcus.ahlstrom@endomines.com
Ingmar Haga, Chairman, +358 40 700 35 18, ingmar.haga@endomines.com

This information is information that Endomines AB is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication through the contact persons set out above at 08:50 CEST on 12 June 2019.

About Endomines 
Endomines is a mining and exploration company with its primary focus on gold. The Company explores for gold along the Karelian Gold Line in Eastern Finland and develops mining operations in Idaho, USA. Endomines aims to improve its long-term growth prospects by increasing its exploration activities and through acquisitions. Endomines aims to acquire deposits that are situated in stable jurisdictions and can be brought to production rapidly with limited investments.

The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM).

Important information

The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in Endomines. Any invitation to the persons concerned to subscribe for shares in Endomines will only be made through the prospectus which Endomines has made public today, June 12, 2019.

This press release may not be released, published or distributed, directly or indirectly, in or into Australia, Hongkong, Japan, Canada, Nya Zeeland, Schweiz, Singapore, United States or any other jurisdiction where participation would require additional prospectuses, registration or measures besides those required by Swedish law. Nor may this press release be distributed in or into such countries or any other country or jurisdiction in which distribution requires such measures or otherwise would be in conflict with applicable regulations. Any failure to comply with the restrictions described may result in a violation of applicable securities regulations.

The subscription rights, paid subscribed shares and shares in Endomines have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States and no subscription rights, paid subscribed shares or shares may be offered, subscribed for, exercised, pledged, sold, resold, granted, delivered or otherwise transferred, directly or indirectly, in or into the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States. There will be no public offering of such securities in the United States.

The securities referred to herein have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the rights issue or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.